Wet (Neovascular / Exudative) Macular Degeneration-Pipeline Insights, 2015

Dec 31, 2015, 09:25 ET from ReportBuyer

LONDON, Dec. 31, 2015 /PRNewswire/ --   Summary

DelveInsight's, Wet (Neovascular / Exudative) Macular Degeneration- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Wet (Neovascular / Exudative) Macular Degeneration. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Wet (Neovascular / Exudative) Macular Degeneration Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight's, Wet (Neovascular / Exudative) Macular Degeneration- Pipeline Insights, 2015 Report covers the Wet (Neovascular / Exudative) Macular Degeneration pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Wet (Neovascular / Exudative) Macular Degeneration related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Wet (Neovascular / Exudative) Macular Degeneration.


*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


- DelveInsight's report provides a Wet (Neovascular / Exudative) Macular Degeneration Landscape across the globe- The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information- Coverage of the Wet (Neovascular / Exudative) Macular Degeneration pipeline on the basis of target, MOA, route of administration, technology involved and molecule type- The report reviews key players involved in the therapeutics development for Wet (Neovascular / Exudative) Macular Degeneration and also provide company profiling- Pipeline products coverage based on various stages of development from NDA filings to discovery.- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Reasons to Buy

- Complete Pipeline intelligence and complete understanding over therapeutics development for Wet (Neovascular / Exudative) Macular Degeneration- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.- Track your competitors and develop strategic initiatives to support your drug development activities.- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.- Understand the market and choose right partners for in-licensing and out licensing for your valuable assets- Understand the factors behind failed/discontinued projects and move ahead without leaving any stone unturned

Download the full report: https://www.reportbuyer.com/product/2841739/

About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com


SOURCE ReportBuyer